Ingeborg Goethals

Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative, and voxel-based methods.

Toward clinical application of neuropsychological activation probes with SPECT: a spatial working memory task.

Is central benzodiazepine receptor imaging useful for the identification of epileptogenic foci in localization-related epilepsies?

Decreased 5-HT2a receptor binding in patients with anorexia nervosa.

False-negative Tc-99m MIBI scintigraphy in histopathologically proved recurrent high-grade oligodendroglioma.

The prefrontal cortex: insights from functional neuroimaging using cognitive activation tasks.

Application of a neuropsychological activation probe with SPECT: the 'Tower of London' task in healthy volunteers.

Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury.

Comparison of cortical 5-HT2A receptor binding in bulimia nervosa patients and healthy volunteers.

Brain perfusion SPECT in impulsivity-related personality disorders.

Differences of cortical 5-HT2A receptor binding index with SPECT in subtypes of anorexia nervosa: relationship with personality traits?

Blunted prefrontal perfusion in depressed patients performing the Tower of London task.

Myocardial perfusion imaging in the elderly: a review.

Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning.

Serotonin transporter and dopamine transporter imaging in the canine brain.

Does regional brain perfusion correlate with eating disorder symptoms in anorexia and bulimia nervosa patients?

Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate single photon emission computed tomography (SPECT) in a euthyroid multinodular goiter.

Validation of a resolution-independent method for the quantification of 123I-FP-CIT SPECT scans.

Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry.

F-18 fluorodeoxyglucose PET/CT scanning in the diagnostic work-up of a primary pericardial mesothelioma: a case report.

Brain activation associated with deep brain stimulation causing dissociation in a patient with Tourette's syndrome.

The potential value of a pictorial atlas for aid in the visual diagnosis of 123I FP-CIT SPECT scans.

Normal uptake of F-18 FDG in the testis as assessed by PET/CT in a pediatric study population.

Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma.

The effect of acquisition time on visual and semi-quantitative analysis of F-18 FDG-PET studies in patients with head and neck cancer.

Support for Warburg's hypothesis using dynamic (18)F-FDG PET in oncology.

Normoglycemic plasma glucose levels affect F-18 FDG uptake in the brain.

Age-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: a 1H-MRS study.

Tumor perfusion using first-pass F-18 FDG PET images.

Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.

Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.

Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation.

The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study.

Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study.

Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study.

Improved HPLC purification strategy for [11C]raclopride and [11C]DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations.

Correlation between individual differences in striatal dopamine and in visual consciousness.

Comparison of EANM and SNM guidelines on diuretic renography in children.

MRI-guided 3D conformal arc micro-irradiation of a F98 glioblastoma rat model using the Small Animal Radiation Research Platform (SARRP).

(18)F-fluoromethylcholine (FCho), (18)F-fluoroethyltyrosine (FET), and (18)F-fluorodeoxyglucose (FDG) for the discrimination between high-grade glioma and radiation necrosis in rats: a PET study.

Comparison of the EANM and SNM guidelines on diuretic renography in children.

The Impact of Accelerated HF-rTMS on the Subgenual Anterior Cingulate Cortex in Refractory Unipolar Major Depression: Insights From 18FDG PET Brain Imaging.

Biological 18[F]-FDG-PET image-guided dose painting by numbers for painful uncomplicated bone metastases: A 3-arm randomized phase II trial.

The role of Size-Specific Dose Estimate (SSDE) in patient-specific organ dose and cancer risk estimation in paediatric chest and abdominopelvic CT examinations.

In vivo quantification of the [(11)C]DASB binding in the normal canine brain using positron emission tomography.

In Vivo Evaluation of Blood Based and Reference Tissue Based PET Quantifications of [11C]DASB in the Canine Brain.

Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (18 F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trial.

Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.

Healthy brain ageing assessed with 18F-FDG PET and age-dependent recovery factors after partial volume effect correction.

18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria.

In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.

Estimation of the optimal dosing regimen of escitalopram in dogs: A dose occupancy study with [11C]DASB.

Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.

Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer.

Hypoxia imaging with F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts.

A feasibility study on adaptive F-FDG-PET-guided radiotherapy for recurrent and second primary head and neck cancer in the previously irradiated territory.

Machine learning based brain tumour segmentation on limited data using local texture and abnormality.

Regional alterations of cerebral [F]FDG metabolism in the chronic unpredictable mild stress- and the repeated corticosterone depression model in rats.

Radiochemotherapy-induced reactivation of scar tissue on F-FDG PET/CT.

Species-dependent extracranial manifestations of a brain seeking breast cancer cell line.

Magnetic resonance imaging-guided radiation therapy using animal models of glioblastoma.

Leigh syndrome followed by parkinsonism in an adult with homozygous c.626C>T mutation in .

The Path Toward PET-Guided Radiation Therapy for Glioblastoma in Laboratory Animals: A Mini Review.

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.

Technical feasibility of [F]FET and [F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model.

PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling.

Cost-Effectiveness of [F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma.

Adjuvant therapeutic potential of tonabersat in the standard treatment of glioblastoma: A preclinical F98 glioblastoma rat model study.

Striatal dopamine D2 binding correlates with locus of control: Preliminary evidence from [C]raclopride Positron Emission Tomography.

Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.

2-[F]FELP, a novel LAT1-specific PET tracer, for the discrimination between glioblastoma, radiation necrosis and inflammation.

Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [F]fluorophenylglutamine and [F]fluorobiphenylglutamine.

Development of a Rat Model for Glioma-Related Epilepsy.

Assessment of the effect of therapy in a rat model of glioblastoma using [18F]FDG and [18F]FCho PET compared to contrast-enhanced MRI.

Comparison of an in-house acquired brain F-18 FDG PET normal database with commercially available normal data.

A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.